Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results

Dova Pharmaceuticals, Inc. (DOVA) Create: Alert

All | News | Filings
Date FiledTypeDescription
11/15/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/12/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/12/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/12/2019 4 Stalfort Sean (Director) has filed a Form 4 on Dova Pharmaceuticals Inc.
Txns: Unknown transaction of 635,665 shares @ $27.5, valued at $17.5M
11/12/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/12/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/12/2019 4 Laliberte Kevin (Sr. VP, Product Development) has filed a Form 4 on Dova Pharmaceuticals Inc.
Txns: Disposed/sold 4,761 shares @ $0
Disposed/sold 115,500 options to buy @ $3.73, valued at $430.8k
Disposed/sold 24,750 options to buy @ $3.73, valued at $92.3k
Disposed/sold 50,000 options to buy @ $8.82, valued at $441k
Disposed/sold 10,000 options to buy @ $16.08, valued at $160.8k
11/12/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/12/2019 4 Hoitt Jason (Chief Commercial Officer) has filed a Form 4 on Dova Pharmaceuticals Inc.
Txns: Disposed/sold 9,970 shares @ $0
Disposed/sold 250,000 options to buy @ $6.07, valued at $1.5M
11/12/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/12/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/12/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/02/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/02/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/02/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/02/2019 4 Hoitt Jason (Chief Commercial Officer) has filed a Form 4 on Dova Pharmaceuticals Inc.
Txns: Sold 2,387 shares @ $28, valued at $66.8k
10/02/2019 4 Laliberte Kevin (Sr. VP, Product Development) has filed a Form 4 on Dova Pharmaceuticals Inc.
Txns: Sold 3,100 shares @ $28, valued at $86.8k
Sold 596 shares @ $28, valued at $16.7k
09/27/2019 4 Laliberte Kevin (Sr. VP, Product Development) has filed a Form 4 on Dova Pharmaceuticals Inc.
Txns: Sold 3,100 shares @ $20, valued at $62k
08/12/2019 4 Manning Paul B (10% Owner) has filed a Form 4 on Dova Pharmaceuticals Inc.
Txns: Bought 28,062 shares @ $15.87, valued at $445.3k
08/01/2019 4 Laliberte Kevin (Sr. VP, Product Development) has filed a Form 4 on Dova Pharmaceuticals Inc.
Txns: Sold 1,389 shares @ $15.97, valued at $22.2k
Granted 10,000 options to buy @ $16.08, valued at $160.8k
08/01/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/16/2019 4 Hoitt Jason (Chief Commercial Officer) has filed a Form 4 on Dova Pharmaceuticals Inc.
Txns: Sold 6,680 shares @ $15.1, valued at $100.9k
Sold 900 shares @ $16.44, valued at $14.8k
07/11/2019 4 PERCEPTIVE ADVISORS LLC (10% Owner) has filed a Form 4 on Dova Pharmaceuticals Inc.
Txns: Bought 29,834 shares @ $16.61, valued at $495.5k
Bought 12,354 shares @ $16.89, valued at $208.7k
Bought 42,916 shares @ $16.67, valued at $715.4k
07/09/2019 4 PERCEPTIVE ADVISORS LLC (10% Owner) has filed a Form 4 on Dova Pharmaceuticals Inc.
Txns: Bought 50,000 shares @ $16.46, valued at $823k
07/03/2019 4 PERCEPTIVE ADVISORS LLC (10% Owner) has filed a Form 4 on Dova Pharmaceuticals Inc.
Txns: Bought 18,121 shares @ $14.24, valued at $258k
Bought 715 shares @ $16.14, valued at $11.5k
Bought 1,705 shares @ $16.67, valued at $28.4k
07/03/2019 4 ZACCARDELLI DAVID (President & CEO) has filed a Form 4 on Dova Pharmaceuticals Inc.
Txns: Sold 5,899 shares @ $15.73, valued at $92.8k
Sold 4,551 shares @ $16.22, valued at $73.8k
07/02/2019 4 Hahn Mark W (CFO) has filed a Form 4 on Dova Pharmaceuticals Inc.
Txns: Sold 1,545 shares @ $14.17, valued at $21.9k
07/02/2019 4 JEFFS ROGER (Director) has filed a Form 4 on Dova Pharmaceuticals Inc.
Txns: Sold 1,308 shares @ $14.17, valued at $18.5k
07/02/2019 4 Laliberte Kevin (Sr. VP, Product Development) has filed a Form 4 on Dova Pharmaceuticals Inc.
Txns: Sold 1,191 shares @ $14.17, valued at $16.9k
07/02/2019 4 ALLEN LEE F MD PhD (Chief Medical Officer) has filed a Form 4 on Dova Pharmaceuticals Inc.
Txns: Sold 1,957 shares @ $14.19, valued at $27.8k
07/02/2019 4 Hoitt Jason (Chief Commercial Officer) has filed a Form 4 on Dova Pharmaceuticals Inc.
Txns: Sold 2,237 shares @ $13.77, valued at $30.8k
Sold 150 shares @ $14.4, valued at $2.2k
07/01/2019 4 PERCEPTIVE ADVISORS LLC (10% Owner) has filed a Form 4 on Dova Pharmaceuticals Inc.
Txns: Bought 140,513 shares @ $12.46, valued at $1.8M
Bought 186,696 shares @ $13.58, valued at $2.5M
Bought 60,617 shares @ $13.97, valued at $846.8k
Bought 39,383 shares @ $14.48, valued at $570.3k
06/27/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/24/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy